4//SEC Filing
Brett-Smith Helena 4
Accession 0000899243-20-004881
CIK 0001563880other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:24 PM ET
Size
5.5 KB
Accession
0000899243-20-004881
Insider Transaction Report
Form 4
Brett-Smith Helena
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-13+30,000→ 30,000 totalExercise: $5.50Exp: 2030-02-12→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 13, 2020. The 30,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 13, 2021 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 13, 2024.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001774731
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 4:24 PM ET
- Size
- 5.5 KB